Journal profile · Pharmacology & Pharmacy
Journal of Asian Natural Products Research
ISSN 1028-6020 · eISSN 1477-2213 · Taylor and Francis Ltd. · ENGLAND · Quarterly · Founded 1998
Journal of Asian Natural Products Research: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1.82; subscription journal; APC charged, amount not published; median 166 days to acceptance (100 articles, last 24 months); community-reported acceptance: about 77.5%; 167 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Journal of Asian Natural Products Research is published by Taylor and Francis Ltd. and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Natural product bioactivities and synthesis, Phytochemistry and Biological Activities and Microbial Natural Products and Biosynthesis, together about 39.1% of its articles. Its main subfields are Molecular Biology. (generated from OpenAlex topic counts and CAS ranking data)
The Journal of Asian Natural Products Research (JANPR) publishes chemical and pharmaceutical studies in the English language in the field of natural product research on Asian ethnic medicine. The journal publishes work from scientists in Asian countries, e.g. China, Japan, Korea and India, including contributions from other countries concerning natural products of Asia. The journal is chemistry-orientated. Major fields covered are: isolation and structural elucidation of natural constituents (including those for non-medical uses), synthesis and transformation (including biosynthesis and biotransformation) of natural products, pharmacognosy, and allied topics. Biological evaluation of crude extracts are acceptable only as supporting data for pure isolates with well-characterized structures. All published research articles in this journal have undergone rigorous peer review, based on initial editor screening and anonymized refereeing by at least two expert referees.
From the journal's Aims & Scope
Research area (LetPub): Pharmacology & Pharmacy
Editor-in-chief Shi-Shan YuPublisher website
Editorial board by country: 9 in mainland China (about 69%); most named Mainland China 9, United States 1, Japan 1, India 1, Thailand 1 (13 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Natural product bioactivities and synthesisBiochemistry, Genetics and Molecular Biology19.7%
- Phytochemistry and Biological ActivitiesAgricultural and Biological Sciences13.7%
- Microbial Natural Products and BiosynthesisMedicine5.7%
- Traditional and Medicinal Uses of AnnonaceaeBiochemistry, Genetics and Molecular Biology4.8%
- Phytochemical compounds biological activitiesBiochemistry, Genetics and Molecular Biology4.5%
- Fungal Biology and ApplicationsMedicine4.3%
- Phytochemistry and Bioactive CompoundsMaterials Science4%
- Marine Sponges and Natural ProductsBiochemistry, Genetics and Molecular Biology3.8%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Chemistry, Applied | Zone 4 |
| Minor | Chemistry, Medicinal | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
| Minor | Plant Sciences | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Plant Sciences | Zone 4 |
| Minor | Chemistry, Applied | Zone 4 |
| Minor | Chemistry, Medicinal | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Chemistry, Applied | Zone 4 |
| Minor | Chemistry, Medicinal | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
| Minor | Plant Sciences | Zone 4 |
Top journal: noReview journal: no
JCR / CiteScore quartiles on the journal's website
- CiteScore Q2 · 2025
Publisher-reported: JCR figures are Clarivate's and CiteScore figures Scopus's to confirm; both are a different system from the CAS zones.Publisher website
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEPubMedCASCAB AbstractsPublisher website
Other: EBSCO, Cambridge Crystallographic Data Centre, EBSCO Databases, Pascal Journal Services, Elsevier Bibliographic Data Base, Abstracts Medicinal Aroma, Cambridge Scientific Abstracts, ISI, New Jour, SciBase
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 1.82LetPub ·
- Impact factor (publisher) 2025
- 1.6Publisher website ·
- 5-year impact factor (publisher) 2025
- 1.6Publisher website ·
- CiteScore 2026-06
- 2.8LetPub ·
- CiteScore (publisher) 2025
- 2.8Publisher website ·
- SJR 2026-06
- 0.29LetPub ·
- SJR (publisher) 2025
- 0.29Publisher website ·
- SNIP 2026-06
- 0.52LetPub ·
- SNIP (publisher) 2025
- 0.52Publisher website ·
- h-index
- 35LetPub ·
- h-index
- 56OpenAlex ·
- i10-index
- 1,708OpenAlex ·
- 2-year mean citedness
- 1.89OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 0%LetPub ·
Volume
- Articles per year
- 166LetPub ·
- Downloads per year (publisher)
- 94,000Publisher website ·
- Downloads per year (publisher) 2025
- 94,000Publisher website ·
Articles by year OpenAlex count · 3,516 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 81 | 2 | 7 |
| 2025 | 167 | 2 | 212 |
| 2024 | 170 | 19 | 570 |
| 2023 | 82 | 6 | 306 |
| 2022 | 125 | 3 | 499 |
| 2021 | 119 | 3 | 894 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
166 daysMedian, submission to acceptance · P25–P75 111 days – 224 days
- Acceptance to online
- median 18 days (100 articles)
- Submission to online
- median 189 days
- Sample
- 100 articles with submission and acceptance dates (277 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 4 monthsLetPub ·
- Average acceptance (community reports)
- 77.5%LetPub ·
- Acceptance rate (publisher)
- 9%Publisher website ·
- Acceptance rate (publisher) 2025
- 9%Publisher website ·
- Submission to first decision
- 2 daysPublisher website ·
- Submission to first decision 2025
- 2 daysPublisher website ·
- First decision after review
- 41 daysPublisher website ·
- First decision after review 2025
- 41 daysPublisher website ·
- Acceptance to publication
- 22 daysPublisher website ·
- Acceptance to publication 2025
- 22 daysPublisher website ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Subscription journalLetPub
A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| Publisher website | Yes, amount not published | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Policy excerpts from the journal's websiteOpen access, Peer review
- Open access Open access
Journal of Asian Natural Products Research is a hybrid open access journal that is part of the Taylor & Francis Open Select publishing program, giving you the option to publish open access. Publishing open access means that your article will be free to access online immediately on publication, increasing the visibility, readership, and impact of your research. Why choose open access? Increase the …
Source ↗Publisher website ·- Peer review
Rigorous peer review based on initial editor screening and anonymized refereeing by at least two expert referees. Model summary
All published research articles in this journal have undergone rigorous peer review, based on initial editor screening and anonymized refereeing by at least two expert referees.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Taylor and Francis Ltd.
- Country or region
- ENGLAND
- Language
- English
- Frequency
- Quarterly
- Founded
- 1998
- ISSN
- 1028-6020
- Electronic ISSN
- 1477-2213
- Latest issue on the website
- Volume 28, Issue 9 (2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Journal of Asian Natural Products Research
What CAS zone is Journal of Asian Natural Products Research in?
In the 2025 upgraded edition of the CAS Journal Ranking, Journal of Asian Natural Products Research is in Zone 4 of Medicine, and in Zone 4 of the minor category Chemistry, Applied / Chemistry, Medicinal / Pharmacology & Pharmacy / Plant Sciences. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Journal of Asian Natural Products Research?
The latest impact factor listed by LetPub is 1.82; CiteScore 2.8, h-index 56.
How long does peer review take at Journal of Asian Natural Products Research?
Based on the dates recorded on 100 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 166 days (interquartile range 111–224 days); authors report an average review time of about 4 months; the community-reported acceptance is “about 77.5%”; the journal's website gives an acceptance rate of 9% (2025). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Journal of Asian Natural Products Research based?
Of the 13 board members whose country the journal's board page names, 9 (about 69%) are in mainland China; the countries named most often are Mainland China (9), United States (1) and Japan (1). Counted from the institutions listed on the board page; for reference only.
Which databases index Journal of Asian Natural Products Research?
According to LetPub and DOAJ records, Journal of Asian Natural Products Research is indexed in SCIE and Scopus. The journal's website also lists MEDLINE, PubMed, CAS and CAB Abstracts; that list has not been checked against each database.
Is Journal of Asian Natural Products Research open access, and what is the APC?
Journal of Asian Natural Products Research is a subscription journal. APC charged, amount not published.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .